Business Description
Fuan Pharmaceutical (Group) Co Ltd
NAICS : 325412
SIC : 2834
ISIN : CNE1000011G4
Share Class Description:
SZSE:300194: Class ACompare
Compare
Traded in other countries / regions
300194.China IPO Date
2011-03-22Description
Fuan Pharmaceutical (Group) Co Ltd is mainly engaged in the production and sales of bulk drugs and preparations. The company mainly deals with anti-infective, anti-tumor, mental nervous system, cardiovascular and cerebrovascular, digestive system, endocrine and metabolic, bone and muscle systems. Its products include penicillin and cephalosporins.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.29 | |||||
| Equity-to-Asset | 0.71 | |||||
| Debt-to-Equity | 0.18 | |||||
| Debt-to-EBITDA | 2.1 | |||||
| Interest Coverage | 9.07 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 2.79 | |||||
| Beneish M-Score | -2.6 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 2.1 | |||||
| 3-Year EBITDA Growth Rate | 7.4 | |||||
| 3-Year EPS without NRI Growth Rate | -60.3 | |||||
| 3-Year Book Growth Rate | 0.4 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 71.34 | |||||
| 9-Day RSI | 69.7 | |||||
| 14-Day RSI | 66.41 | |||||
| 6-1 Month Momentum % | -17.86 | |||||
| 12-1 Month Momentum % | -8.5 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.77 | |||||
| Quick Ratio | 1.22 | |||||
| Cash Ratio | 0.81 | |||||
| Days Inventory | 199.24 | |||||
| Days Sales Outstanding | 40.06 | |||||
| Days Payable | 102.27 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.17 | |||||
| Dividend Payout Ratio | 0.22 | |||||
| 5-Year Yield-on-Cost % | 1.17 | |||||
| Shareholder Yield % | 1.2 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 51.48 | |||||
| Operating Margin % | 9.96 | |||||
| Net Margin % | 9.7 | |||||
| FCF Margin % | 11.95 | |||||
| ROE % | 6.49 | |||||
| ROA % | 4.36 | |||||
| ROIC % | 4.87 | |||||
| ROC (Joel Greenblatt) % | 18 | |||||
| ROCE % | 7.43 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 19.82 | |||||
| PE Ratio without NRI | 18.87 | |||||
| Shiller PE Ratio | 43.6 | |||||
| PS Ratio | 1.92 | |||||
| PB Ratio | 1.21 | |||||
| Price-to-Tangible-Book | 1.49 | |||||
| Price-to-Free-Cash-Flow | 16.15 | |||||
| Price-to-Operating-Cash-Flow | 9.66 | |||||
| EV-to-EBIT | 13.4 | |||||
| EV-to-EBITDA | 13.4 | |||||
| EV-to-Revenue | 1.76 | |||||
| EV-to-FCF | 14.83 | |||||
| Price-to-Projected-FCF | 1.54 | |||||
| Price-to-Median-PS-Value | 0.76 | |||||
| Price-to-Graham-Number | 1.12 | |||||
| Price-to-Net-Current-Asset-Value | 12.82 | |||||
| Earnings Yield (Greenblatt) % | 7.46 | |||||
| FCF Yield % | 6.37 | |||||
| Forward Rate of Return (Yacktman) % | 22.09 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Fuan Pharmaceutical (Group) Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 2,766.127 | ||
| EPS (TTM) (Â¥) | 0.22 | ||
| Beta | 1.06 | ||
| Volatility % | 31.07 | ||
| 14-Day RSI | 66.41 | ||
| 14-Day ATR (Â¥) | 0.164748 | ||
| 20-Day SMA (Â¥) | 3.961 | ||
| 12-1 Month Momentum % | -8.5 | ||
| 52-Week Range (Â¥) | 2.92 - 5.15 | ||
| Shares Outstanding (Mil) | 1,189.71 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Fuan Pharmaceutical (Group) Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Fuan Pharmaceutical (Group) Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Fuan Pharmaceutical (Group) Co Ltd Frequently Asked Questions
What is Fuan Pharmaceutical (Group) Co Ltd(SZSE:300194)'s stock price today?
The current price of SZSE:300194 is ¥4.36. The 52 week high of SZSE:300194 is ¥5.15 and 52 week low is ¥2.92.
When is next earnings date of Fuan Pharmaceutical (Group) Co Ltd(SZSE:300194)?
The next earnings date of Fuan Pharmaceutical (Group) Co Ltd(SZSE:300194) is .
Does Fuan Pharmaceutical (Group) Co Ltd(SZSE:300194) pay dividends? If so, how much?
The Dividend Yield %  of Fuan Pharmaceutical (Group) Co Ltd(SZSE:300194) is 1.17% (As of Today), Highest Dividend Payout Ratio of Fuan Pharmaceutical (Group) Co Ltd(SZSE:300194) was 5. The lowest was 0.15. And the median was 0.39. The  Forward Dividend Yield % of Fuan Pharmaceutical (Group) Co Ltd(SZSE:300194) is 0%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers